Tweet
<img alt="" height="1" width="1" />
Salix shares up after FDA clears liver disorder drug
Reuters
(Reuters) - Salix Pharmaceuticals Ltd (SLXP.O) shares rose 9 percent in premarket trade Thursday, a day after the US health regulator approved the use of its Xifaxan antibiotic as a treatment for reducing the risk of a debilitating liver disorder in ...
Ahead of the Bell: Salix Pharmaceuticals risesBusinessWeek
Salix Pharmaceuticals Ltd. Has Climbed To A New High On FDA NewsRTT News
Market Report -- In Play (SLXP)MSN Money
Genetic Engineering News (press release) -ONN.tv -Trading Markets (press release)
all 90 news articles »
More...